HR 6342
112th Congress
House
Health
Business records
Drug safety, medical device, and laboratory regulation
Drug therapy
Health technology, devices, supplies
Long-term, rehabilitative, and terminal care
Prescription drugs
Retail and wholesale trades
Trade restrictions
Compassionate Freedom of Choice Act of 2012
Introduced: August 2, 2012
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Aug 3, 2012
Referred to the Subcommittee on Health.
Aug 3, 2012
Sponsor introductory remarks on measure. (CR E1407-1409)
Aug 2, 2012
Referred to the House Committee on Energy and Commerce.
Aug 2, 2012
Introduced in House
Plain-English summary
Compassionate Freedom of Choice Act of 2012 - Amends the Federal Food, Drug, and Cosmetic Act to declare that nothing in it or in the Public Health Service Act shall prevent or restrict, and the Food and Drug Administration (FDA) shall not implement or enforce any law to prevent or restrict, the importation, distribution, or sale of investigational drugs or devices for terminally ill patients.
Prohibits the FDA Commissioner from requiring the disclosure, collection, or reporting of certain information concerning such drugs or devices, except that the sponsor of a clinical trial may voluntarily disclose, collect, or report such information to the FDA.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2
Cosponsors
1